Scan to Download
One power score. Smarter investment decisions
Maze Therapeutics Inc
MAZE32.260USD
+1.770+5.81%
Close 11/11, 16:00（ET）Quotes delayed by 15 min
30.490USD+30.490After-hours 11/12, 20:00 (ET)
1.55BMarket Cap
LossP/E TTM
Maze Therapeutics Inc
32.260
+1.770+5.81%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
Total equity
Cash, cash equivalents and short-term investments
156.63%383.94M
51.11%264.54M
--294.37M
--196.81M
--149.61M
--175.06M
- Cash and cash equivalents
111.74%316.77M
51.11%264.54M
--294.37M
--196.81M
--149.61M
--175.06M
-Short-term investments
--67.16M
----
----
----
----
----
Prepaid expenses
69.40%7.37M
52.49%6.61M
--5.33M
--4.86M
--4.35M
--4.33M
Other current assets
----
--0.00
--0.00
----
----
----
Total current assets
154.16%391.30M
51.14%271.15M
--299.71M
--201.67M
--153.96M
--179.40M
Non-current assets
Net Fixed Assets
-14.46%26.46M
-13.84%27.71M
--28.80M
--29.92M
--30.93M
--32.16M
Other non-current assets
-43.39%4.30M
10.07%4.66M
--4.34M
--8.95M
--7.59M
--4.23M
Total non-current assets
-20.16%30.76M
-11.06%32.37M
--33.13M
--38.87M
--38.52M
--36.40M
Total assets
119.27%422.06M
40.65%303.52M
--332.84M
--240.54M
--192.48M
--215.79M
Liabilities
Current liabilities
-Other payables
----
--0.00
--0.00
----
----
----
Accrued expenses
23.30%14.43M
8.41%11.52M
--11.54M
--14.10M
--11.70M
--10.62M
Deferred liabilities
----
----
----
----
----
--2.50M
Other current liabilities
----
-100.00%0.00
--0.00
----
----
--2.50M
Total current liabilities
25.96%22.11M
-7.89%19.90M
--18.62M
--20.67M
--17.55M
--21.61M
Non-current liabilities
Long-term debt and lease liabilities
-73.95%19.42M
-72.07%20.29M
--21.15M
--22.00M
--74.54M
--72.66M
-Long-term debt
----
----
----
--0.00
--51.75M
--49.10M
-Long-term lease liabilities
-14.81%19.42M
-13.88%20.29M
--21.15M
--22.00M
--22.80M
--23.56M
Other non-current liabilities
7.81%1.09M
--1.09M
--1.01M
--969.00K
--1.01M
----
Total non-current liabilities
-72.85%20.51M
-70.57%21.38M
--22.16M
--22.96M
--75.56M
--72.66M
Total liabilities
-54.22%42.62M
-56.21%41.28M
--40.77M
--43.64M
--93.11M
--94.27M
Shareholders' equity
Common equity
2743.33%834.35M
2468.61%687.13M
--683.28M
--47.24M
--29.34M
--26.75M
Retained earnings
-44.96%-454.98M
-46.96%-424.89M
---391.21M
---358.43M
---313.88M
---289.12M
Capital reserves
2743.36%834.30M
2470.66%687.09M
--683.24M
--47.24M
--29.34M
--26.73M
Gains losses not affecting retained earnings
--69.00K
----
----
----
----
----
Total equity
281.84%379.44M
115.78%262.24M
--292.07M
--196.90M
--99.37M
--121.53M
Currency unit
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
